Astrid Weiss Selected Research

Precision Medicine

1/2021

Kinases as potential targets for treatment of pulmonary hypertension and right ventricular dysfunction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Astrid Weiss Research Topics

Disease

6	Pulmonary Arterial Hypertension 05/2024 - 01/2019
5	Vascular Remodeling 12/2023 - 01/2013
5	Pulmonary Hypertension 01/2023 - 01/2013
4	Fibrosis (Cirrhosis) 01/2023 - 01/2019
4	Neoplasms (Cancer) 12/2022 - 01/2012
4	Hypoxia (Hypoxemia) 01/2022 - 01/2019
2	Familial Primary Pulmonary Hypertension 05/2024 - 01/2013
2	Cardiomegaly (Heart Hypertrophy) 01/2023 - 01/2019
2	Glioblastoma (Glioblastoma Multiforme) 12/2022 - 07/2012
2	Right Ventricular Hypertrophy 01/2021 - 06/2020
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2023
1	Ventricular Remodeling 01/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2022
1	Emphysema 01/2022
1	Cardiotoxicity 01/2021
1	Right Ventricular Dysfunction 01/2021
1	Hypertrophy 01/2019
1	Breast Neoplasms (Breast Cancer) 07/2012

Drug/Important Bio-Agent (IBA)

4	MonocrotalineIBA 01/2023 - 01/2013
2	DisulfidesIBA 12/2023 - 01/2019
2	SurvivinIBA 02/2014 - 07/2012
2	Peptides (Polypeptides)IBA 07/2012 - 01/2012
1	Insulin-Like Growth Factor Binding Protein 2IBA 05/2024
1	Insulin-Like Growth Factor Binding ProteinsIBA 05/2024
1	Insulin-Like Growth Factor Binding Protein 1IBA 05/2024
1	Insulin-Like Growth Factor Binding Protein 3IBA 05/2024
1	Auranofin (Ridaura)FDA Link 12/2023
1	CyclinsIBA 12/2023
1	AcyltransferasesIBA 01/2023
1	Surface-Active Agents (Surfactants)IBA 01/2023
1	CateninsIBA 01/2023
1	Janus KinasesIBA 01/2023
1	MethyltransferasesIBA 12/2022
1	DNA (Deoxyribonucleic Acid)IBA 12/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2022
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2022
1	SmokeIBA 01/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2022
1	EnzymesIBA 01/2022
1	regorafenibIBA 02/2021
1	ruxolitinibIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Oxygen (Dioxygen)IBA 06/2020
1	palbociclibIBA 01/2019
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2019
1	LyasesIBA 01/2019
1	polysulfideIBA 01/2019
1	Semaxinib (SU5416)IBA 01/2019
1	CystathionineIBA 01/2019
1	Metformin (Glucophage)FDA LinkGeneric 01/2019
1	Inhibitor of Differentiation Protein 1IBA 01/2013
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2013
1	Sildenafil Citrate (Viagra)FDA Link 01/2013
1	Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)IBA 01/2013
1	Small Interfering RNA (siRNA)IBA 07/2012
1	ApoferritinsIBA 07/2012
1	Proteins (Proteins, Gene)FDA Link 07/2012
1	ThioredoxinsIBA 07/2012
1	Recombinant Fusion ProteinsIBA 07/2012

Therapy/Procedure

4	Therapeutics 01/2021 - 07/2012
1	Precision Medicine 01/2021
1	Transplantation 07/2012